Skip to content
PICO Portalanswers from OpenAlex

Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia

PaperCitations, authors & open-access status

Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia is a paper indexed in PICO Portal from OpenAlex.

How many citations does Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia have?

PICO Portalcitation count

Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia has 1,216 citations in the OpenAlex counts PICO Portal stores.

When was Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia published?

PICO Portalyear

Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia has 2006 year in the PICO Portal index.

What is the open-access status of Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia?

PICO Portaloa status

Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia has bronze oa status in the PICO Portal index.

What is the DOI of Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia?

PICO Portaldoi

The DOI for Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia is on the source record.

What is the PMID of Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia?

PICO Portalpmid

The PMID for Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia is on the source record.

What is the OpenAlex record for Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia?

PICO Portalopenalex

The OpenAlex for Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial